Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 10, 2011, Pages 2082-2094

  Lee, Kyunghee ^a   Kim, Hyunsoo ^a   Kim, Jin Man ^a   Kim, Jae Ryong ^a   Kim, Keuk Jun ^b   Kim, Yong Jin ^a   Park, Se Il ^a   Jeong, Jae Ho ^c   Moon, Young mi ^c   Lim, Hyun Sook ^d   Bae, Dong Won ^e   Kwon, Joseph ^f   Ko, Chang Yong ^g   Kim, Han Sung ^g   Shin, Hong In ^h   Jeong, Daewon ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Taekyeung College   (South Korea)

^c Noblesse Plastic Surgery and Stem Tec Korea   (South Korea)

^d Hanyang Women's University   (South Korea)

^e Gyeongsang National University   (South Korea)

^f Korea Basic Science Institute (KBSI)   (South Korea)

^g Yonsei University Wonju   (South Korea)

^h Kyungpook National University   (South Korea)

Author keywords

Adipose derived stem cell; Osteoblast; Osteoclast; Osteoporosis; Systemic transplantation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ADIPOCYTE; ANIMAL; ARTICLE; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; OSTEOBLAST; OSTEOCLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION;

ADIPOCYTES; ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; MAP KINASE KINASE 4; MICE; OSTEOBLASTS; OSTEOCLASTS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

MUS;

EID: 80053284870     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01230.x     Document Type: Article

References (53)

1. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005; 115: 3318-25.
2. Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007; 13: 791-801.
3. Mimeault M, Batra SK. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells. 2006; 24: 2319-45.
4. Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 2008; 4: 27-49.
5. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007; 100: 1249-60.
6. Lien CY, Chih-Yuan Ho K, Lee OK, et al Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 2009; 24: 837-48.
7. Zuk PA, Zhu M, Ashjian P, et al Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13: 4279-95.
8. Corre J, Barreau C, Cousin B, et al Human subcutaneous adipose cells support complete differentiation but not self-renewal of hematopoietic progenitors. J Cell Physiol. 2006; 208: 282-8.
9. Cai L, Johnstone BH, Cook TG, et al IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells. 2009; 27: 230-7.
10. Rehman J, Traktuev D, Li J, et al Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004; 109: 1292-8.
11. Kilroy GE, Foster SJ, Wu X, et al Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol. 2007; 212: 702-9.
12. Wei X, Zhao L, Zhong J, et al Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett. 2009; 462: 76-9.
13. Lee K, Kye M, Jang JS, et al Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer. Proteomics. 2004; 4: 3343-52.
14. Kim H, Choi HK, Shin JH, et al Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest. 2009; 119: 813-25.
15. Lee SH, Rho J, Jeong D, et al v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006; 12: 1403-9.
16. Huh YJ, Kim JM, Kim H, et al Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ. 2006; 13: 1138-46.
17. Grano M, Galimi F, Zambonin G, et al Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA. 1996; 93: 7644-8.
18. Delany AM, Kalajzic I, Bradshaw AD, et al Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology. 2003; 144: 2588-96.
19. Zhu S, Barbe MF, Liu C, et al Periostin-like-factor in osteogenesis. J Cell Physiol. 2009; 218: 584-92.
20. Globus RK, Doty SB, Lull JC, et al Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci. 1998; 111: 1385-93.
21. Menaa C, Esser E, Sprague SM. Beta2-microglobulin stimulates osteoclast formation. Kidney Int. 2008; 73: 1275-81.
22. Carron JA, Wagstaff SC, Gallagher JA, et al A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro. Biochem Biophys Res Commun. 2000; 270: 1124-7.
23. Datta NS, Abou-Samra AB. PTH and PTHrP signaling in osteoblasts. Cell Signal. 2009; 21: 1245-54.
24. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006; 116: 1186-94.
25. Scutt A, Bertram P. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res. 1995; 10: 474-87.
26. Rickard DJ, Kazhdan I, Leboy PS. Importance of 1, 25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone. 1995; 16: 671-8.
27. Ogasawara T, Kawaguchi H, Jinno S, et al Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6. Mol Cell Biol. 2004; 24: 6560-8.
28. Chang J, Wang Z, Tang E, et al Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med. 2009; 15: 682-9.
29. Kim WS, Park BS, Sung JH, et al Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007; 48: 15-24.
30. Nakagami H, Maeda K, Morishita R, et al Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005; 25: 2542-7.
31. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998: S7-21.
32. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002; 84-A: 1032-44.
33. Allen MR, Hock JM, Burr DB. Periosteum: biology, regulation, and response to osteoporosis therapies. Bone. 2004; 35: 1003-12.
34. Howard GA, Turner RT, Sherrard DJ, et al Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1, 25-dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3. J Biol Chem. 1981; 256: 7738-40.
35. D'Ippolito G, Schiller PC, Perez-stable C, et al Cooperative actions of hepatocyte growth factor and 1, 25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone. 2002; 31: 269-75.
36. Smith JW, Piotrowicz RS, Mathis D. A mechanism for divalent cation regulation of beta 3-integrins. J Biol Chem. 1994; 269: 960-7.
37. Adamopoulos IE, Xia Z, Lau YS, et al Hepatocyte growth factor can substitute for M-CSF to support osteoclastogenesis. Biochem Biophys Res Commun. 2006; 350: 478-83.
38. Miyazaki T, Katagiri H, Kanegae Y, et al Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol. 2000; 148: 333-42.
39. Matsumoto M, Sudo T, Saito T, et al Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem. 2000; 275: 31155-61.
40. David JP, Sabapathy K, Hoffmann O, et al JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci. 2002; 115: 4317-25.
41. Li F, Wang X, Niyibizi C. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells. 2007; 25: 3183-93.
42. Lynch MP, Stein JL, Stein GS, et al The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res. 1995; 216: 35-45.
43. Hankenson KD, Bornstein P. The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res. 2002; 17: 415-25.
44. Thapa N, Kang KB, Kim IS. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone. 2005; 36: 232-42.
45. Xu K, Zhang Y, Ilalov K, et al Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. J Biol Chem. 2007; 282: 11347-55.
46. Hayami T, Kapila YL, Kapila S. MMP-1 (collagenase-1) and MMP-13 (collagenase-3) differentially regulate markers of osteoblastic differentiation in osteogenic cells. Matrix Biol. 2008; 27: 682-92.
47. Mosig RA, Dowling O, DiFeo A, et al Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet. 2007; 16: 1113-23.
48. Nordstrom SM, Carleton SM, Carson WL, et al Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization. Bone. 2007; 41: 995-1004.
49. Everts V, Korper W, Hoeben KA, et al Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res. 2006; 21: 1399-408.
50. Matsumoto N, Jo OD, Shih RN, et al Increased cathepsin D release by Hyp mouse osteoblast cells. Am J Physiol Endocrinol Metab. 2005; 289: E123-32.
51. Raouf A, Ganss B, McMahon C, et al Lumican is a major proteoglycan component of the bone matrix. Matrix Biol. 2002; 21: 361-7.
52. Zambuzzi WF, Yano CL, Cavagis AD, et al Ascorbate-induced osteoblast differentiation recruits distinct MMP-inhibitors: RECK and TIMP-2. Mol Cell Biochem. 2009; 322: 143-50.
53. Geoffroy V, Marty-Morieux C, Le Goupil N, et al In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res. 2004; 19: 811-22.